Dermal filler Teosyal RHA 4 is a sterile gel made from crosslinked sodium hyaluronate; RHA stands for Resilient Hyaluronic Acid. The FDA has approved the filler for correction of moderate-to-severe facial wrinkles and folds, and it is intended for administration into the deep dermis to superficial subcutaneous tissue. Dermal filler Teosyal RHA 4 is designed to add volume to extended areas of the face such as the cheeks, enhancing and contouring these zones. To ensure the absence of discomfort during procedures, Lidocaine is part of Teosyal RHA 4’s formulation.
Dermal filler Teosyal RHA 4 is used as a volumizer to combat one of the primary signs of aging – skin that is slackening and drooping. Patients start to lose their youthful appearance when sagging skin is present in the midface. By adding hydration and volume, dermal filler Teosyal RHA 4 fights the atrophy that leads to a face that perpetually looks tired. The patented process used to create the product’s hyaluronic acid gives it the ability to stretch and adapt in areas that experience a great deal of movement while creating facial expressions. This leads to outcomes that look natural both when the face is static and when it moves.
Dermal filler Teosyal RHA 4 is indicated for treating lipoatrophy through the restoration of volume to facial areas such as the cheeks. It is also indicated for filling in deep lines, correcting the eyelids, and defining the contours of the face. Teosyal RHA 4’s effects last from six to nine months and should be followed by maintenance visits at least once a year.
Dermal filler Teosyal RHA 4 is made of bio-fermented sodium hyaluronate that is crosslinked. The hyaluronic acid concentration is 23 mg/ml, and Lidocaine is included at a concentration of 3 mg/ml. One ml of gel comes in each of two pre-filled syringes accompanied by sterile 27G1/2” needles. Dermal filler Teosyal RHA 4 is manufactured in Switzerland by Teoxane Laboratories.